retatrutide phase 2 results 2024 2025 UK Guide: Key Facts on the New Weight-Loss Drug Summary of the highest percent

Temporary nerve dysfunction post-surgery can resolve

We understand that starting a new medication can be daunting, and our team is dedicated to providing guidance and support to manage any potential side effects, such as nausea or gastrointestinal discomfort, ensuring a smooth transition for our patients

Pirro V, et al

Bharti monitors your progress, manages any side effects, and adjusts your dosage to ensure you are meeting your weight loss goals efficiently

Unlike semaglutide , which targets only the GLP-1 receptor, or tirzepatide , which targets GLP-1 and GIP receptors, retatrutide activates all three metabolic receptors at once

What are compounded GLP-1 medications